Digital Marketing Trends Reshaping Women's Health in 2025

Women's health marketing has a money problem worth paying attention to. Core women's health and adjacent conditions add up to roughly $430 to $440 billion globally right now, and PwC expects that to clear $600 billion by 2030. That's a category the size of a mid-sized country's economy, and treating it like a footnote to "general health" marketing is how a brand loses ground it doesn't get back.

The femtech slice, meaning apps, wearables, and platforms built specifically for women's bodies, is outrunning even that broader market. Grand View Research put global femtech at $39.29 billion in 2024, heading toward $97.25 billion by 2030, while women's health apps alone hit $5.76 billion in 2025, growing at 17.81% a year, and venture capital caught the scent early, with Silicon Valley Bank clocking $2.6 billion in women's health VC funding in 2024, up almost a billion from the year before. So what does that much money pouring into one sector actually mean for someone planning a campaign? The field got crowded fast, and crowded fields punish anyone still marketing like it's 2019, since when several well-funded competitors chase the same customer with similar products, the winner is usually whoever understood the channel best. There's a bigger structural reason this audience matters, too: women make most household healthcare decisions, and reach them well online, and the payoff spreads past a single segment into the market as a whole.

What follows is a walk through five collisions happening right now: telehealth, influencer dynamics, ad suppression, AI personalization, and the direct-to-consumer playbook. Each one asks something different of a marketer trying to keep up, and none of them ask nicely.

How telehealth moved from pandemic workaround to primary acquisition channel for women's health brands

Telehealth saw heavy use during lockdowns, and interest dipped for many categories once waiting rooms reopened. In women's health, it stayed relevant well past that point, settling in as a primary front door for care.

Start with the access problem, because it explains more than any strategy deck could. As of 2024, nearly 47% of U.S. counties have no practicing OB-GYN, according to AAMC data. Almost half the country has zero specialists nearby, so telehealth brands are building bridges straight across that gap, marketing into places where the nearest exam room might be a two-hour drive away.

Demand followed, predictably. Wheel's 2025 Virtual Care Horizons report found virtual care visits tied to women's health jumped 276% between Q1 and Q4 of 2024. Seventy-three percent of virtual care users identify as female, making telehealth one of the most concentrated women's health audiences in digital media. The 2024 KFF Women's Health Survey backs this up from the ground level: 48% of women had a phone or virtual visit with a provider in the prior two years, which puts telehealth firmly in the middle of the bell curve rather than early-adopter territory.

The category is projected to grow at a 13.09% compound annual rate, the fastest-growing service segment in women's healthcare by that measure. Here's where a lot of marketing budgets quietly go to waste, though: there are two separate motions happening under one umbrella, and treating them as the same thing is a mistake.

The first is direct-to-consumer, the patient searching for a virtual OB-GYN visit at 11pm because next month's appointment slots are gone. The second is business-to-business, and it might be the bigger structural story of the two. Seventy-five percent of companies now say women's health benefits are a priority for attracting and keeping talent. Fertility benefit adoption among large U.S. employers hit 40% in 2024, and platforms like Carrot Fertility, Progyny, and Maven Clinic sell not to patients but to HR departments and benefits administrators, with a different sales cycle, a different decision-maker, and different content.

For content strategy, it comes down to one thing: women showing up in telehealth funnels are usually solving a problem, often an urgent one, and they want friction removed. A plain explainer on what a virtual visit costs and whether it's private will outconvert a beautifully researched symptom blog post most of the time, because access beats education when the woman on the other end already knows something's wrong. She just needs to know how to get help, fast.

Why influencer marketing works differently in women's health than in almost any other category

Fifty-seven percent of women ages 18 to 29 get health and wellness information from influencers, according to Pew Research Center. That's 10 points higher than young men in the same bracket, and it's not a rounding error.

The engagement runs deeper than passive scrolling. Around 51% of young women who get health info from influencers say wanting to change something about their own health is a major reason they follow that content at all, and these are people looking for a reason to act. Ogilvy found 70% of people generally seek out health content on social media, so the habit itself isn't unique to this category. What's different is the weight the topic carries. Periods, fertility, menopause, pelvic floor issues: these are subjects loaded with enough stigma that most women won't bring them up at lunch with a coworker, and the anonymity of a creator relationship fills a gap a doctor's office visit rarely does.

Platform mechanics back this up. On TikTok, nano-influencers make up 87.7% of creators and post the highest engagement rate of any tier, 10.3%, according to HypeAuditor. Relevance beats reach here, consistently. Relevance beats reach here, consistently. A creator with 4,000 followers who only talks about perimenopause symptoms will often outperform a celebrity wellness account with two million, because the small creator gets trusted the way a knowledgeable friend gets trusted. Health and medical education content has become among the fastest-growing categories on Instagram, too, so this audience isn't stumbling onto the content by accident. They're hunting for it, on purpose, at 11pm, same as the telehealth searchers from the last section.

The smartest brands here figured out that a medical credential is a shortcut to trust no production budget can buy. Whitelisting content from OB-GYNs, registered dietitians, and certified pelvic floor physical therapists does two things at once: it builds credibility fast, and it tends to dodge the platform misinformation flags that snag sloppier health content. Medical creators talk the way a clinician talks to a patient, plainly, and that register performs well organically, then amplifies cleanly when boosted through tools like TikTok's Spark Ads. A brand partnering with a credentialed micro-creator who only covers postpartum pelvic floor recovery is going to beat a broad lifestyle influencer buy scattered across a vague audience.

None of this happens in a vacuum, though. Researchers have documented non-evidence-based claims circulating on TikTok, Instagram, and Facebook, including fertility tests and menopause supplements with no real clinical backing behind them, and every brand in this space has to sit with that tension. The gap between accurate content and the noise around it is a genuine marketing asset, but only if the brand's own claims are airtight first. Lead with clinical accuracy in a feed full of unverified advice, and a brand starts sounding like the one voice in the scroll that actually knows what it's talking about.

The ad suppression problem that is quietly reshaping how women's health brands build their content

Here's a number that should stop any marketer in this category mid-scroll: industry research has found a large share of businesses in women's health and sexual wellness had ads rejected on Meta, with similar rejection rates reported on Google and product listings pulled from Amazon. Broader surveys of brands, creators, clinicians, and consumers have found the vast majority had run into at least one censorship issue with women's health content across major platforms. This is a routine occurrence rather than an edge case.

The double standard is documented, not a hunch. Documented cases have emerged where platforms approved men's health ads while rejecting comparable women's health content outright. Women's health providers have had ads blocked repeatedly while similar men's health campaigns sailed through without a second look. Mostly it's an automated filter making the call, not a human reviewer: it flags words like "menstrual," "PMS," "menopause," or "sexual health," regardless of whether a licensed OB-GYN wrote the copy. The algorithm can't tell a scam supplement from a board-certified physician explaining perimenopause; it just sees the flagged word and pulls the post.

The money involved isn't abstract, either. Affected brands have reported significant revenue losses from these restrictions, with costs mounting across both Amazon and Meta. Real revenue vanishes because a keyword filter can't tell "vaginal dryness" from spam, and nobody's building a better filter fast enough.

Brands stopped absorbing this quietly, though. Some femtech companies have begun pursuing regulatory and legal channels to challenge platform bias instead of just posting about it and hoping. Women's health leaders have issued collective warnings that platforms are systematically misclassifying accurate content about menstruation, fertility, and menopause as adult material. That kind of pushback is starting to build its own brand equity, since audiences notice which companies fight for the right to talk about their own bodies, and that fight becomes part of the story people tell about the brand.

Meanwhile, the workarounds keep getting sharper. Brands are shifting from clinical, anatomical imagery toward lifestyle visuals: a woman out for a walk, reading on a couch, generally at ease, instead of a diagram or a product shot. Copy gets rewritten to keep the meaning while dodging the flagged term, "support for life's changes" instead of "relief for vaginal dryness." Brands are learning to speak in code to survive an algorithm that was never built with them in mind. Some run AI pre-screening tools to test copy for compliance before launch, with backup creative ready to swap in the second something gets flagged, while others lean harder into organic content and the credentialed creator partnerships from the last section, treating paid platforms as unreliable ground and owned or earned reach as the actual hedge.

What AI-powered personalization is making possible in women's health content and why data privacy complicates it

Machine learning models can now sift through cycle and symptom data to spot patterns, predict fertile windows, and flag possible hormonal imbalances. Women's health goes from something addressed once a year at an appointment to something tracked continuously, day by day. That shift, episodic care to constant data, changes what "personalized content" can even mean. A brand can meet a specific woman at a specific moment: postpartum, mid-perimenopause, three months into cycle tracking, with something that actually applies to her instead of one generic menopause post blasted to everyone.

The apps are where regular people feel this shift most. Leading cycle-tracking apps have amassed millions of users worldwide, and the menstrual health apps market alone reached $2.07 billion in 2025 and is headed toward $13.11 billion by 2035. For a marketer standing outside those platforms, that creates a real problem: the most engaged, data-rich audiences in this whole category are locked inside apps that control both the data and the relationship. Getting in front of them usually means a partnership deal or a platform placement, not an open programmatic buy.

But how does a brand personalize responsibly when the data is this sensitive? Cycle tracking, fertility signals, pregnancy status: this is about as personal as data gets, and evolving legal and regulatory scrutiny in the U.S. has turned mishandling that data into a real legal risk for the women involved, not just a PR headache for the company holding it. A brand that gets this wrong risks more than a fine. It risks the one asset this whole category runs on, which is trust.

The brands paying attention have started treating privacy as an actual selling point rather than boilerplate buried in a terms-of-service page nobody opens. Encryption, no third-party data sharing, on-device processing where it's technically doable: these show up front and center in marketing now, because data ethics has become a real differentiator in a market where everyone is quietly wondering who else can see this.

So what does that mean for the people producing the content day to day? AI speeds up the mechanics: drafting condition-specific messaging, adjusting tone for different life stages, translating for multilingual audiences faster than any human team could manage alone. The judgment calls, though, what's medically defensible, what reads as tone-deaf, what crosses a regulatory line, still need a human who understands the clinical and legal terrain to sign off. Speed without that judgment is how a brand ends up in next year's CensHERship survey instead of staying out of it.

How direct-to-consumer femtech brands are building marketing strategies that bypass traditional healthcare gatekeepers

Traditional healthcare marketing runs on slow regulatory review, ad platforms that flag your keywords, and physicians who decide what patients even get told. DTC femtech brands looked at that whole structure and built around it.

The pattern repeats across the category. Newsletters, podcasts, and branded community apps build owned audiences that don't vanish the moment a platform tweaks its algorithm overnight. Education becomes the entry point: a plain-language explainer on what perimenopause actually feels like, a symptom guide, a recorded Q&A with a clinician, none of which trips the same restrictions a direct product ad would. Once someone's in, conversion happens through subscriptions and ongoing relationships, an app, a supplement refill, a telehealth membership, rather than a single purchase. That builds the kind of lifetime-value data that justifies spending more to acquire each customer, because the brand actually knows that customer is worth more over time than a one-off buyer.

The employer benefits channel from the telehealth section doubles as a DTC accelerant here, too. Win a fertility benefit contract or a menopause program with a large employer, and suddenly a brand has a pre-qualified, high-intent audience walking straight through benefits enrollment, which is about as close to guaranteed distribution as this category gets.

Closed communities offer something paid ads structurally can't replicate. Private Facebook groups, Discord servers, in-app forums: these spaces mostly dodge ad-policy flagging because they aren't ads, and they run hotter than an open feed because everyone in the room chose to be there. Women swapping notes on symptoms and treatments inside a brand-hosted space generate organic social proof that no paid campaign, however sharply targeted, can fake. The brand's job shifts from talking at people to hosting the room, and that builds the slow, durable loyalty this category rewards over the flashier wins other industries chase.

None of it works without a content team that can move at the speed the category demands. Publishing has to stay steady, matching an audience expecting an always-on presence rather than a quarterly campaign burst. Content needs to cover the whole decision journey, from someone typing "what is perimenopause" into a search bar for the first time to someone comparing three apps to someone actually signing up. Every claim needs a regulatory check before it goes out, not a walk-back after a platform flags it. Speed also matters more here than most places: a new clinical study, or a celebrity going public about menopause, can demand a response within days, and the brand that turns content around fast has a real edge over the one still waiting on a review cycle.

What marketers need to carry forward from these trends into actual campaign planning

One pattern runs through all five trends: this audience is sharp, motivated, and consistently underserved by generic health marketing. Women aren't stumbling into telehealth apps or medical creator content by accident. They're actively searching, usually after hitting a wall somewhere else, whether that's a six-week wait for an OB-GYN appointment or an ad that got yanked before it ever reached them.

That has practical consequences beyond the strategy deck. Budget needs to split cleanly between consumer acquisition and employer-benefits marketing, because they're different sales cycles with different buyers, and treating them as one motion wastes money on both sides. Influencer partnerships should favor credentialed, niche voices over broad reach, since relevance converts better than impressions in a category this personal. Paid media plans need a built-in hedge against ad suppression: organic content and owned channels carry real weight in the strategy now, not just fallback options. AI speeds up production, sure, but every claim still needs a human who understands the clinical and legal stakes to sign off before it goes live. And DTC brands building owned communities and subscription relationships keep proving the same point: the slow trust-building approach beats the fast transactional one here, again and again.

A lot of health marketing skipped this work for years because it was easier to run the playbook built for an entirely different category. Women's health runs on its own playbook now, and the brands still borrowing someone else's are the ones paying for it, one rejected ad and one lost customer at a time.